Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Other financing activities (2021)

ENDRA Life Sciences (NDRA) has disclosed Other financing activities for 2 consecutive years, with $10052.0 as the latest value for Q4 2021.

  • Quarterly Other financing activities changed N/A to $10052.0 in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $10052.0 through Dec 2021, changed N/A year-over-year, with the annual reading at $35953.0 for FY2025, N/A changed from the prior year.
  • Other financing activities for Q4 2021 was $10052.0 at ENDRA Life Sciences, down from $60910.0 in the prior quarter.
  • The five-year high for Other financing activities was $10052.0 in Q4 2021, with the low at $10052.0 in Q4 2021.